POZ - Latino Hub : Treatment News

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
|
|
|
|
|
|
|
|
|

Back to home » News & Views » Treatment News


 
October 31, 2007
HIV Treatment Greatly Improves Brain Illness Survival
October 30, 2007
Is Once-Daily Kaletra an Effective Dosing Option?
Pre-treatment CD4 Count Predicts CD4 Gains on Treatment
October 29, 2007
Kaletra Tablets for Children Show Equivalency
Small Steps Forward in HIV Prevention
October 27, 2007
Alive and Well: Ten Years of HAART in Advanced HIV Cohort
Crestor Bests Pravachol for Elevated Lipids
New Menu of Antiviral Options
Children and Challenges: Treating Pediatric HIV
October 26, 2007
Safer Family Planning for Positive Couples
Why Do Those With HIV Have More Heart Attacks?
Rilpivirine Comparable to Sustiva in Treatment First-Timers
More Rash With Once-Daily Viramune
Similar Efficacy, Better Triglycerides with Invirase vs. Kaletra
Tesamorelin (TH9507) Safe and Effective for 52 Weeks
October 25, 2007
Strategies for Success With Kaletra Monotherapy
More Promising Data on Selzentry for Drug-Resistant HIV
Aiming Low: 'Undetectable' Not Just for Treatment Newbies
October 24, 2007
Poor Adherence May Explain Worse Sustiva Responses Among Blacks
October 23, 2007
Low Body Weight, Not HIV, Linked to Frail Bones
Kaletra Reduces HIV in the Brain
October 19, 2007
Committee Recommends Approval of Atripla in Europe
ESRD Nearly Six Times Higher in African Americans With HIV
October 18, 2007
HIV Increases Risk of Heparin-Induced Thrombocytopenia
October 17, 2007
Today's Patients Seek HIV Care Later Than Those in 1990
October 16, 2007
Rapid Liver Damage Possible in HIV/HCV Patients
Researchers Recommend Screening for Pulmonary Arterial Hypertension
October 12, 2007
New Study Finds Alcohol Use and Depression Influence Adherence
Norvir Dose Lowered for Use With Lexiva
October 10, 2007
Stress May Contribute to HIV Disease Progression
People on a Failing HIV Regimen May Still See Benefit
October 09, 2007
HIV Treatments Protective Against Brain Damage
October 08, 2007
Better Quality of Life for People With HIV Who Quit Smoking
October 04, 2007
Needle-Free Fuzeon Abandoned for Now
October 03, 2007
Key Protein Blunts Immune System’s Power to Fight HIV
October 02, 2007
Tesamorelin Promising for Lipodystrophy Over 52 Weeks
Scientists Discover a Way to Reach Hidden HIV
October 01, 2007
Acetyl-L-Carnitine Promising for Neuropathy

 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
 
Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.